Bennen Bierman
Podiatrist · Worthington, MNNPI 1255953675
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (49.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Sioux Surgical Inc at 52.7% of the total. Reporting peaked in 2022 at $1,786 and has fallen 84.2% since, to $281 in 2025.
Across 42 payments — averaging $115.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sioux Surgical Inc$3K
- Stryker$906
- Conetic Solutions, Inc.$714
- Arthrex$205
- Smith+Nephew$205
- Treace Medical Concepts, Inc.$70
- plus $192 from 5 others
What the payments were for
- Travel & lodging$61813%
- Food & beverage$1,82538%
- Education$2,40050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sioux Surgical Inc | 4 | $2,552 |
| Stryker | 15 | $906 |
| Conetic Solutions, Inc. | 7 | $714 |
| Arthrex | 4 | $205 |
| Smith+Nephew | 3 | $205 |
| Treace Medical Concepts, Inc. | 1 | $70 |
| Organogenesis Inc. | 3 | $62 |
| BD | 1 | $44 |
| Polynovo North America LLC | 2 | $39 |
| Kerecis Limited | 1 | $31 |
| Solventum Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$293
- PROPHECY$175
- STRAVIX MESH$146
- 7 X 23MM CITRELOCK IMPLANT$106
How this compares
$4,843 in reported general payments places this provider in the 80th percentile of 105 podiatrist providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 35 | $335 |
| Gabapentin | 15 | $202 |
| Meloxicam | 58 | $146 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $102 |
| Doxycycline Hyclate | 13 | $96 |
| Oxycodone Hcl | 18 | $68 |
| Ondansetron Hcl | 18 | $41 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Worthington
- Stephen MariashSartell$45K
- Walter EllisSt Cloud$23K
- Lindsey HjelmSartell$18K
- Nathan SandersAlbert Lea$17K
- Grace OuyangMadelia$14K
- Nicholas StaubRichfield$12K
- Benjy OlsenDetroit Lakes$11K
- Jacob HarderBrainerd$11K
- Kimberly BobbittMinneapolis$11K
- Sharilyn MooreForest Lake$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.